Skip to main content

Find Clinical Trials

Home
Conditions
Marginal Zone Lymphoma

Clinical trial condition

Marginal Zone Lymphoma

Explore clinical trials studying Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.

114 public trials 41 recruiting studies

Refine in advanced search Browse all conditions

Marginal Zone Lymphoma trial results

Completed

Evaluation of Atezolizumab-Venetoclax-Obinutuzumab Combination in Relapse/Refractory Lymphomas

NCT03276468

Conditions: Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +14 more
Locations: CHU d'Angers Angers, France

CHU de Caen Caen, France

CHU de Clermont Ferrand - Estaing Clermont-Ferrand, France

Hopital Henri Mondor Créteil, France

View all 25 locations

View Trial Details

Completed

Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT01647971

Conditions: B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +33 more
Locations: TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States

TG Therapeutics Investigational Trial Site Jonesboro, Arkansas, United States

TG Therapeutics Investigational Trial Site Athens, Georgia, United States

TG Therapeutics Investigational Trial Site Macon, Georgia, United States

View Trial Details

Completed

Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Idelalisib in Japanese Participants With Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphomas (iNHL) or Chronic Lymphocytic Leukemia (CLL)

NCT02242045

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +24 more
Locations: Aichi, Japan

Miyagi, Japan

Tokyo, Japan

View Trial Details

Completed

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

NCT01474681

Conditions: Acute Lymphocytic Leukemia, Acute Myelocytic Leukemia, Bone Marrow Diseases, +51 more
Locations: Novartis Investigative Site Minneapolis, Minnesota, United States

View Trial Details

Completed

Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma

NCT01239875

Conditions: Adult Diffuse Mixed Cell Lymphoma, Adult Diffuse Small Cleaved Cell Lymphoma, Adult Grade III Lymphomatoid Granulomatosis, +37 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone Lymphoma

NCT01980628

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Site Reference ID/Investigator# 837 Tucson, Arizona, United States

Site Reference ID/Investigator# 047 Duarte, California, United States

Site Reference ID/Investigator# 377 Santa Monica, California, United States

Site Reference ID/Investigator# 763 West Palm Beach, Florida, United States

View all 25 locations

View Trial Details

Completed

Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas

NCT01282424

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
Locations: St. Jude Medical Center Fullerton, California, United States

Pacific Shores Medical Group Long Beach, California, United States

UCLA Los Angeles, California, United States

Central Coast Medical Oncology Santa Maria, California, United States

View all 41 locations

View Trial Details

Completed

Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant

NCT00880815

Conditions: CD20 Positive, Chronic Disease, Chronic Lymphocytic Leukemia, +28 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymphoma

NCT01306643

Conditions: Chronic Disease, Disease Attributes, Follicular Lymphoma, +22 more
Locations: Stanford Cancer Center Palo Alto, California, United States

Mount Sinai School of Medicine New York, United States

View Trial Details

Completed

Lenalidomide and R-CHOP in B-cell Lymphoma

NCT00901615

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: CHU de Dijon Dijon, France

CHRU Lille Lille, France

CHU Lyon Sud Pierre-Bénite, France

Centre Henri Becquerel Rouen, France

View Trial Details